(Q43477405)

23 November 2017

title

Randomized trial of a medical food for the dietary management of chronic, stable angina (English)

1 reference

23 November 2017

Andrew J Maxwell

1

1 reference

23 November 2017

Michael P Zapien

2

1 reference

23 November 2017

Greg L Pearce

3

1 reference

23 November 2017

Gail MacCallum

4

1 reference

23 November 2017

Peter H Stone

5

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Journal of the American College of Cardiology

23 November 2017

published in

1 reference

23 November 2017

volume

39

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

37-45

1 reference

Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Oral L-arginine in patients with coronary artery disease on medical management

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Effects of infusion of L-arginine on exercise-induced myocardial ischemic ST-segment changes and capacity to exercise of patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

L-Arginine Improves Endothelium-Dependent Relaxation of Conductance and Resistance Coronary Arteries in Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Which antihypertensive drug classes have been shown to be beneficial? What are their benefits? A critique of hypertension treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Regression or progression. Dependency on vascular nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: a multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901708-9

7 January 2021

10.1016/S0735-1097(01)01708-9

Identifiers

DOI

1 reference

23 November 2017

1 reference